- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Platinum-resistant Recurrent Ovarian Cancer in Sweden
Total 99 results
-
Mersana TherapeuticsIQVIA Biotech; PSI CRORecruitingPlatinum Resistant Ovarian Cancer | Non Small Cell Lung Cancer MetastaticUnited States, Spain, United Kingdom, Australia, France, Austria, Belgium, Bulgaria, Canada, Czechia, Denmark, Finland, Hungary, Italy, Lithuania, New Zealand, Norway, Poland, Sweden
-
AGO Research GmbHARCAGY/ GINECO GROUP; Australia New Zealand Gynaecological Oncology Group; Arbeitsgemeinschaft... and other collaboratorsCompletedRecurrent Platinum-sensitive Ovarian CancerFrance, Belgium, Germany, Australia, United Kingdom, Austria
-
Aprea TherapeuticsCompletedPlatinum Sensitive Recurrent High-grade Serous Ovarian Cancer With Mutated p53United States, France, Spain, Netherlands, United Kingdom, Belgium, Germany, Sweden
-
Göteborg UniversityArvid Carlsson Research ABRecruitingDepressive Disorder | Depression | Depressive Disorder, Treatment-Resistant | Depressive Episode | Recurrent Depressive Disorder | Recurrent DepressionSweden
-
Uppsala University HospitalUppsala University; The Netherlands Cancer InstituteRecruitingOvarian Cancer RecurrentSweden
-
BayerCompletedAdvanced Recurrent Malignant Pleural Epithelioid Mesothelioma | Advanced Recurrent Malignant Peritoneal Epithelioid Mesothelioma | Advanced Recurrent Serous Ovarian Cancer | Advanced Pancreatic Ductal Adenocarcinoma (Optional, Dose Expansion, Not Initiated)United States, Sweden, Netherlands, United Kingdom, Finland
-
AGO Research GmbHHoffmann-La RocheActive, not recruitingRecurrent Ovarian CarcinomaNorway, Spain, France, Switzerland, Denmark, Germany, Sweden, Belgium, Finland, Austria, Estonia, Lithuania
-
Region VästerbottenUmeå UniversityRecruitingCervix Cancer | Endometrial Cancer | Epithelial Ovarian CancerSweden
-
Catharina Ziekenhuis EindhovenRecruitingRecurrent Rectal CancerNetherlands, Sweden, Belgium, Norway, Portugal
-
Karolinska InstitutetSkane University HospitalActive, not recruitingAdvanced Ovarian CancerSweden
-
Universitaire Ziekenhuizen KU LeuvenUZ Leuven, Leuven, Belgium; Policlinico Universitario A. Gemelli, IRCSS, Rome... and other collaboratorsRecruitingCervical Cancer | Ovarian Neoplasms | Ovarian Cancer | Metastatic Cancer | Pelvic Cancer | Endometrial Cancer | Ovarian Carcinoma | Uterus Cancer | Sarcoma UterusBelgium, Czechia, Italy, Sweden
-
Uppsala University HospitalNorrlands Universitetssjukhus, Umea, SwedenRecruitingOvarian Cancer | Fallopian Tube Cancer | Peritoneal CancerSweden
-
Vastra Gotaland RegionThe Swedish Research Council; Sahlgrenska University Hospital, Sweden; Swedish...Completed
-
Göteborg UniversityUmeå University; Vastra Gotaland RegionRecruiting
-
Karolinska University HospitalRecruitingStomach Neoplasms | Pancreatic Neoplasms | Epithelial Ovarian Cancer | Bile Duct NeoplasmsSweden
-
Karlstad Central HospitalUnknown
-
Göteborg UniversityCompletedPolycystic Ovary Syndrome | Insulin ResistanceSweden
-
Vejle HospitalCompletedEpithelial Ovarian CancerDenmark, Belgium, Sweden, Austria
-
Umeå UniversityKarolinska Institutet; Lund University; Göteborg UniversityEnrolling by invitationLynch Syndrome | Hereditary Breast and Ovarian Cancer Syndrome | Familial Breast Cancer | Hereditary Breast Cancer | Familial Colorectal CancerSweden
-
Astellas Pharma a/sCompletedMetastatic Castration Resistant Prostate CancerSweden
-
Jeffrey Yachnin M.D., PhD.SanofiCompletedMetastatic Castration Resistant Prostate CancerSweden
-
Tesaro, Inc.European Network of Gynaecological Oncological Trial Groups (ENGOT); US Oncology... and other collaboratorsCompletedA Maintenance Study With Niraparib Versus Placebo in Patients With Platinum Sensitive Ovarian CancerOvarian Neoplasms | Platinum Sensitive Ovarian CancerUnited States, Belgium, Sweden, Germany, Israel, Austria, Canada, Denmark, Spain, Italy, United Kingdom, Poland, France, Hungary, Norway
-
Lokon Pharma ABUppsala UniversityActive, not recruitingColorectal Cancer | Pancreatic Adenocarcinoma | Ovarian Cancer | Biliary CarcinomaSweden
-
Preben Kjolhede, MD, professorCompleted
-
Kancera ABNordic Society of Gynaecological Oncology - Clinical Trials UnitRecruitingFallopian Tube Cancer | Epithelial Ovarian Cancer | Peritoneal CancerDenmark, Norway, Sweden
-
University Hospital, LinkoepingVastra Gotaland Region; Region Jönköping County; Region Västerbotten; Västervik...RecruitingEpithelial Ovarian CancerSweden
-
Lund UniversitySwedish Cancer Foundation; ALF Swedish Government GrantCompletedProstate Cancer RecurrentSweden
-
University of Southern DenmarkMinistry of the Interior and Health, Denmark; Danish Clinical Intervention...CompletedOvarian Neoplasms | Fallopian Tube NeoplasmsDenmark, Sweden
-
Karolinska University HospitalSahlgrenska University Hospital, Sweden; University Hospital, Linkoeping; Lund... and other collaboratorsUnknownDelayed Gastric Emptying | Esophagectomy | No Signs of Cancer RecurrenceSweden
-
AIO-Studien-gGmbHSanofi; ClinAssess GmbHTerminatedBreast Cancer | Lung Cancer | Recurrent Brain Metastases | Progressive Brain MetastasesGermany
-
Sahar SalehiRecruiting
-
BayerCompletedMetastatic Castration-Resistant Prostate CancerSweden
-
St. James's Hospital, IrelandKarolinska Institutet; St Mary's Hospital, Paddington, LondonCompletedEsophageal Cancer | Chemoradiation | Chemotherapy | Surgery | Metastatic Cancer | Radiation | Recurrent Esophageal CancerSweden, Ireland, United Kingdom
-
AstraZenecaKuDOS Pharmaceuticals LimitedCompletedOvarian NeoplasmUnited States, Spain, Australia, Germany, Sweden
-
Uppsala UniversitySwedish Cancer SocietyCompleted
-
SanofiRegeneron PharmaceuticalsCompletedNeoplasms | Cancer of the OvaryUnited States, France, Canada, Australia, Germany, Italy, Netherlands, Portugal, Spain, Sweden, Switzerland
-
AbbVie (prior sponsor, Abbott)BiogenCompletedOvarian Cancer, Primary Peritoneal CancerUnited States, Australia, Belgium, Italy, Poland, Russian Federation, Spain, Sweden, Switzerland
-
Karolinska InstitutetKarolinska University Hospital; Peking UniversityRecruitingPolycystic Ovary Syndrome | Hyperandrogenism | Insulin ResistanceSweden, China
-
European Organisation for Research and Treatment...Eastern Cooperative Oncology Group; Southwest Oncology Group; Scandinavian Sarcoma...CompletedSarcoma | Kidney Cancer | Ovarian Cancer | Metastatic Cancer | Endometrial Cancer | PheochromocytomaSweden
-
University College London HospitalsCompletedBreast Cancer | Hereditary Breast/Ovarian Cancer (brca1, brca2) | brca1 Mutation Carrier | brca2 Mutation CarrierAustralia, Israel, United Kingdom, Spain, Sweden, Portugal
-
SpectraCure ABRecruitingRecurrent Prostate CancerUnited States, Canada, United Kingdom, Sweden
-
Bristol-Myers SquibbOno Pharmaceutical Co. LtdCompletedStage IV or Recurrent Non-Small Cell Lung CancerUnited States, Finland, Argentina, France, Italy, Brazil, Greece, Japan, Mexico, Romania, Spain, Sweden, United Kingdom, Australia, Austria, Belgium, Canada, Czechia, Germany, Hungary, Korea, Republic of, Netherlands, Poland, Switzerland and more
-
Oasmia Pharmaceutical ABCompletedFallopian Tube Cancer | Epithelial Ovarian Cancer | Primary Peritoneal CancerUkraine, Belarus, Belgium, Bulgaria, Croatia, Czech Republic, Denmark, Finland, Hungary, Latvia, Lithuania, Romania, Russian Federation, Serbia, Slovakia, Sweden
-
AstraZenecaParexel; Covance; Iqvia Pty Ltd; Theradex; Myriad Genetics, Inc.CompletedNon-Germline BRCA Mutated Ovarian CancerItaly, Spain, Sweden, Canada, Czechia, Poland, United Kingdom, Israel, Austria, Belgium, Switzerland, Netherlands, Bulgaria, Finland, Norway, Denmark, Slovenia, Portugal
-
AstraZenecaCompletedOvarian NeoplasmsSpain, United States, Belgium, United Kingdom, Israel, Poland, Germany, Sweden, Australia
-
AGO Study GroupActive, not recruitingOvarian CancerUnited States, France, Germany, Austria, Sweden, Denmark, Italy, United Kingdom
-
Boehringer IngelheimCompletedOvarian NeoplasmsBelgium, France, Slovakia, Spain, Sweden
-
Lund University HospitalRecruiting
-
GOG FoundationNational Cancer Institute (NCI)CompletedRecurrent Uterine Corpus Carcinoma | Stage IIIA Uterine Corpus Cancer AJCC v7 | Stage IIIB Uterine Corpus Cancer AJCC v7 | Stage IIIC Uterine Corpus Cancer AJCC v7 | Stage IVA Uterine Corpus Cancer AJCC v7 | Stage IVB Uterine Corpus Cancer AJCC v7United States, Canada, Japan
-
Sahlgrenska University Hospital, SwedenThe Swedish Research Council; Sjöbergstiftelsen; VGregionRecruitingGynecologic Cancer | Malignant Neoplasm | Malignant Neoplasm of Large Intestine | Malignant Neoplasm of Colon | Malignant Neoplasm of Prostate | Malignant Neoplasm of Rectum | Malignant Neoplasm of Anus | Malignant Neoplasm of Urinary Bladder | Malignant Neoplasm of Cervix | Malignant Neoplasm of OvarySweden